Ten local researchers learned last week that they will receive grants from the Independent Citizens' Oversight Committee (ICOC) of the California Institute for Regenerative Medicine, the state agency created by California voters to pursue the promise of stem cells in science and medicine.
Also, for the first time, the governing board approved an award funding a human clinical trial testing a stem cell-derived therapy. The award to Menlo Park-based Geron, Corp, help them with an on-going early phase trial for people with spinal cord injury.
The local grants include eight to UCSD researchers totaling $10.891 million and two to Scripps Research Institute for $3.5 million.
UCSD researchers receiving funds are:
— David Cheresh, Ph.D., professor of pathology, UCSD Moores Cancer Center;
— Anirvan Ghosh, Ph.D., professor and chair of the Neurobiology Section of the Division of Biological Sciences;
— Charles C. King, Ph.D., associate research scientist in the Department of Pediatrics,
— Farah Sheikh, Ph.D., assistant professor, Division of Cardiology, Department of Medicine;
— Deborah Spector, Ph.D., professor, Skaggs School of Pharmacy and Pharmaceutical Sciences;
— Gene Yeo, Ph.D., assistant professor, Department of Cellular and Molecular Medicine; n Binhai Zheng, Ph.D., associate professor, Department of Neurosciences, and
— Kun Zhang, assistant professor, Department of Bioengineering, Jacobs School of Engineering and the UCSD Institute for Genomic Medicine.
From the Scripps Research Institute Professor Joel Gottesfeld and Assistant Professor Kristin Baldwin will receive grants .